{"nct_id":"NCT05631795","title":"Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2022-08-09","start_date_type":"ACTUAL","primary_completion_date":"2025-06-12","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-12","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}